Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox in Healthy Volunteers
NCT04402762Phase 2Completed
- Sponsor
- Universitas Indonesia
- Start
- Dec 2019
- Primary completion
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes, Allosteric Modulators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ovine enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Maximum activity and Area under the effect curve. Started Dec 2019; status: completed.
02
Drugs
ovine enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04402762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04402762.